High MT3 expression showed a marginal significance for predicting poor outcome in the RCC cohort.
← all excerpts
<i>DDX3X</i> is Epigenetically Repressed in Renal Cell Carcinoma and Serves as a Prognostic Indicator and Therapeutic Target in Cancer Progression.
1
—
—